FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · Individuals 12 years of age and older are eligible to receive a single dose of the updated, approved Comirnaty or the updated, approved Spikevax; if previously vaccinated, the dose is...
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 · Approval of Spikevax (COVID-19 Vaccine, mRNA) to include the 2023-2024 formula, a change to a single dose for individuals 18 years of age and older, and approval of a single dose for individuals...
News Details
WEBAug 22, 2024 · Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna's updated vaccine is expected to be available in the coming days.
Spikevax (COVID-19 Vaccine, mRNA) 2024-2025 Formula - Moderna
WEBLearn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2024-2025 Formula and how it helps protect against emerging variants, following ACIP recommendation.
Coronavirus (COVID-19) Update: FDA Takes Key Action by …
WEBJan 31, 2022 · Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
WEBSep 11, 2023 · SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
New COVID-19 vaccines were just approved: Everything you need to ... - WBEZ
WEBAug 25, 2024 · Those who are at least 12 years old can get a single dose of the updated Comirnaty or Spikevax vaccine, according to the FDA.
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax
WEBJan 31, 2022 · Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax. Approval based on a comprehensive submission package including efficacy and safety data approximately six months after second dose. SPIKEVAX has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel. 807 ...
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
WEBDec 30, 2020 · The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus...
FDA fully approves Moderna COVID vaccine, Spikevax
WEBToday the US Food and Drug Administration (FDA) granted full approval to the mRNA COVID-19 vaccine made by Moderna, which will now be known as Spikevax. The vaccine had been authorized for emergency use for more than a year and has been a mainstay of the US vaccination campaign.
Skip to content